Parkinson's disease: focus on neuropsychiatric disorders
https://doi.org/10.37586/2686-8636-3-2020-205-211
Abstract
Parkinson's disease is a multisystem neurodegenerative disease with damage to various neurotransmitters systems and a wide range of neuropsychiatric disorders (NPS). NPS are typical manifestations of PD, occurring in most patients, and are the leading factors that reduce the quality of life. In this article, the epidemiology, clinical course, diagnosis, and management of some of the most common NPS symptoms in PD are discussed. The issues of combination, the presence of common structural and neurochemical pathophysiological mechanisms, and potential approaches to therapy were reviewed.
About the Author
M. N. Nodel
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University); Pirogov Russian National Research Medical University of Ministry of Health of the Russian Federation, Russian Gerontology Research and Clinical Centre
Russian Federation
Russian Federation
MD, PhD, professor, Department of Nervous Diseases and Neurosurgery Institute of Clinical Medicine named after N.V. Sklifosovsky Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University).
Moscow.
+ 7(915) 480-41-81
Scopus Author ID: 24464053000
References
1. Nodel' M.R., Yakhno N.N. Nervous and mental disorders of Parkinson's Disease. Neurology, Neuropsychiatry, Psychosomatics. 2009; 1(2): 3-8 (In Russ.). DOI: 10.14412/2074-2711-2009-30.
2. D. Aarsland, L. Marsh, A. Schrag. Neuropsychiatric Symptoms in Parkinson's Disease. Mov Disord 2009 Nov; 24(15): 2175-86. DOI: 10.1002/mds.22589.
3. R. Postuma, D. Berg, M. Stern, W. Poewe, C.W. Olanow, W. Oertel, J. Obeso, K. Marek, et. al. MDS Clinical Diagnostic Criteria for Parkinson's Disease. Movement Disorders 2015 ; Vol. 30(12): 1591-1599. DOI: 10.1002/mds.26424.
4. Wu Y.H., Lee W.J., Chen Y.H., Chang M.H., Lin C.H. Premotor Symptoms as Predictors of Outcome in Parkinsons Disease: A Case-Control Study. PLoS ONE 2016 ; 11(8): e0161271. DOI: 10.1371.
5. Berg D., Postuma R.B., Adler C.H., Bloem B.R., Chan P., Dubois B., Gasser T., Goetz C.G., Halliday G., Joseph L., Lang A.E., Liepelt-Scarfone I., Litvan I., Marek K., Obeso J., Oertel W., Olanow C.W., Poewe W., Stern M., Deuschl G. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015 Oct; 30(12): 1600-11. DOI: 10.1002/mds.26431.
6. Hely M.A., Morris J.G., Reid W.G., Trafficante R. Sydney Multicenter Study of Parkinson's Disease: non-L-dopa-responsive Problems Dominate at 15 Years. Mov Disord 2005 Feb; 20(2): 190-9. DOI: 10.1002/mds.20324.
7. Nodel M.R. The impact of neuropsychiatric symptoms on quality of life of patients with Parkinsons disease. Neurologicheskiy zhurnal. 2015; 1: 20-25 (in Russian) DOI: 10.18821/1560-9545-2015-20-27:1-20-27.
8. McKinlay A., Grace R.C., Dalrymple-Alford J.C., et. al. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinsons disease. Park. and Relat. disord. 2008; 14: 37-42. DOI: 10.1016/j.parkreldis.2007.05.009.
9. G.W. Duncan, T.K. Khoo, A.J. Yarnall, J.T. O'Brien, S.Y. Coleman, D.J. Brooks, R.A. Barker, D.J. Burn. Health-related Quality of Life in Early Parkinson's Disease: The Impact of Nonmotor Symptoms. Mov Disord 2014; 29(2): 195-202. DOI: 10.1002/mds.25664.
10. U. Ehrt, K. Br0nnick, A.F.G. Leentjens, J.P. Larsen, D. Aarsland. Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease. Int J Geriatr Psychiatry 2006; 21: 252-258. DOI: 10.1002/gps.1456.
11. Starkstein S.E., Merello M., Jorge R., et. al. A validity study of depressive syndromes in Parkinsons disease. Mov.Dis. 2008; 23: 538-546.
12. Marsh L., McDonald W.M., Cummings J., et. al. NINDS/NIMH Work Group on Depression and Parkinsons Disease. Provisional diagnostic criteria for depression in. Provisional diagnostic criteria for depression in Parkinsons Disease: report of an NINDS/ NIMH Work Group. Mov.Dis. 2006; 21: 148-158.
13. Nodel M.R. The anxiety in Parkinson's disease. Neurologicheskiy zhurnal. 2018; 4: 176-183 (in Russian) DOI: 10.188211/1560-9545-2018-230-4176183.
14. Rutten S., van der Ven P.M., Weintraub D., Pontone G.M., Leentjens A.F.G., Berendse H.W., et. al. Predictors of anxiety in early-stage Parkinson's disease — Results from the first two years of a prospective cohort study. Parkinsonism Relat Disord. 2017; 43: 49-55. DOI: 10.1016/j.parkreldis.2017.06.024.
15. Pfeiffer H.C., L0kkegaard A., Zoetmulder M., Friberg L., Werdelin L. Cognitive impairment in early-stage non-demented Parkinson's disease patients. Acta Neurol Scand. 2014 May; 129(5): 307-18. DOI: 10.1111/ane.12189.
16. Aarsland D., Kurz M.W. The epidemiology of dementia associated with Parkinson disease. J Neurol Sci. 2010; 15; 289(1-2): 18-22. DOI: 10.1016/j.jns.2009.08.034.
17. K.F. Pedersen, J.P. Larsen, O.-B. Tysnes, G. Alves. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol. 70 (2013): 580-586. DOI: 10.1001/jamaneurol.2013.2110.
18. Stiopkina D.A., Zakharov V.V., Yakhno N.N. Cognitive disturbances in the progression of Parkinson's disease. Zurnal neurologii i psikhiatrii im. S.S. Korsakova. 2008; 10: 13-9.
19. de Mamdreville A.D., Fenelon G., Mahieux F. Hallucinations in Parkinson's disease: a follow-up study. Movement Disorder 2005; 20( 2): 212-7. DOI: 10.1002/mds.20263.
20. Nodel M.R., Danilova N.N., Glozman J.M., Yakhno N.N. The relationship between cognitive and emotional-affective disturbances in patients with Parkinson's disease. Neurologicheskiy zhurnal. 2016; 6: 338-343] DOI: 10.188211/1560-9545-2016-21-6-338-343.
21. Seppi K., Chaudhuri K.R., Coelho M., Fox S.H., Katzenschlager R., Lloret S.P., Weintraub D., Sampaio C.. Update on Treatments for Nonmotor Symptoms of Parkinson's Disease — An Evidence-Based Medicine Review. Movement Disorder 2019; 34(2): 180-189. DOI: 10.1002/mds.27602.
22. Golubev V.L., Kamakinova A.B. Nonpharmacological therapy in complex rehabilitation treatment in patients with Parkinsons disease. Neurologia. Neuropsichiatria. Psychosomatica. 2014; (4): 4-10 (in Russian) DOI: 10.14412/2074-2711-2014-4-4-10.
Review
For citations:
Nodel M.N. Parkinson's disease: focus on neuropsychiatric disorders. Russian Journal of Geriatric Medicine. 2020;(3):205-211. (In Russ.) https://doi.org/10.37586/2686-8636-3-2020-205-211
Views:
6892
Email this article 